2-102718794-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032718.5(MFSD9):c.1051C>A(p.Gln351Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,613,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032718.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152238Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250068Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135476
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461464Hom.: 0 Cov.: 34 AF XY: 0.00000413 AC XY: 3AN XY: 727030
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152356Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74508
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1051C>A (p.Q351K) alteration is located in exon 6 (coding exon 6) of the MFSD9 gene. This alteration results from a C to A substitution at nucleotide position 1051, causing the glutamine (Q) at amino acid position 351 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at